Composition
Salmeterol and Fluticasone Propionate Inhalation I.P.
Description
ARV-FLOW (Salmeterol and Fluticasone Propionate Inhalation I.P.) is a combination inhalation therapy used for the long-term management of asthma and chronic obstructive pulmonary disease (COPD). It combines Salmeterol, a long-acting bronchodilator, with Fluticasone Propionate, an inhaled corticosteroid, to improve airflow, reduce airway inflammation, and help prevent asthma symptoms and COPD exacerbations. Manufactured under stringent quality standards, Arvantis Pharmaceuticals ensures safe, effective, and reliable inhalation therapy with consistent therapeutic performance. It is ideal for hospital supply, PCD Pharma Franchise, third-party manufacturing, institutional procurement, and bulk distribution across Delhi and India.
Enter your details to start WhatsApp chat